Psychometric evaluation of the National Kidney Dialysis and Kidney Transplantation Study symptom checklist: Reliability and validity

Nephrology Dialysis Transplantation

Volumn 24, Issue 2, 2009, Pages 619-625

  Spiegel, David M ^a,d   Evans, Roger W ^b   Gitlin, Matthew ^c   Mayne, Tracy J ^c  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^b Evans Health   (United States)

^c AMGEN INC   (United States)

^d NONE   (United States)

Author keywords

Anaemia; Dialysis; Health related quality of life; Reliability; Symptoms

Indexed keywords

ADULT; AGED; ARTICLE; CHECKLIST; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; TEST RETEST RELIABILITY; TREATMENT RESPONSE; VALIDITY;

ADULT; AGED; ANEMIA; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 58449084696     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn523     Document Type: Article

References (29)

1. U.S. Renal Data System, USRDS. 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007
2. Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989; 35: 134-148
3. Eschbach JW. Erythropoietin: the promise and the facts. Kidney Int 1994; 45(Suppl 44): S70-S76
4. Transfusion Guidelines. America's blood centers. ABC blood bulletin. Available at http://www.americasblood.org. Accessed on 04 June 2007
5. Transfusion Guidelines. American red cross blood services, New England region, maine, massachusetts, New Hampshire, vermont. Available at http://www.newenglandblood.org. Accessed on 14 February 2008
6. Transfusion Guidelines. New York Council on Human Blood and Transfusion Services. 2nd edn, 2004. Available at www.wadsworth.org/labcert/ blood-tissue. Accessed on 14 February 2008
7. Yonga HH, Gibsona, SJ, Horneb DJ et al. Development of a pain attitudes questionnaire to assess stoicism and cautiousness for possible age differences. J Gerontol B Psychol Sci Soc Sci 2001; 56: 279-284
8. Breumelhof R, Smout AJ. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991; 86: 160-164
9. Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labeling claims. Guidance for Industry. Rockville, MD: Food and Drug Administration, 2006, Draft Guidance. http://www.fda.gov/cder/guidance/index.htm. Accessed on 14 February 2008
10. Ries P. Americans Assess Their Health, United States,1978. U.S. Vital and Health Statistics: Data from the National Health Survey Series 10, No. 142. Washington DC: US Public Health Service; 1983. DHHS Publication 83-1570
11. Data on file, Amgen. A double-blind placebo-controlled study of recombinant human erythropoietin (r-HuEPO) in hemodialysis patients. Study 87-001, 1988
12. Data on file, Amgen. A double-blind placebo-controlled study of recombinant human erythropoietin (r-HuEPO) in peritoneal dialysis patients. Study 89-004, 1993
13. Evans R, Manninen DL, Garrison L et al. Healthcare Financing Special Report: Findings from the National Kidney Dialysis and Kidney Transplantation Study. Baltimore, MD: U.S. Department of Health and Human Services, Health Care Financing Administration, 1987, HCFA publication 03230
14. Evans R, Rader B, Manninen D. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA 1990; 263: 825-830
15. Evans RW, Manninen DL, Garrison LP Jr et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312: 553-559
16. Jansen JP, Evans CE, Guyot P et al. The impact of Epoetin alfa on the symptoms of anemia: a Bayesian meta-analysis of clinical trials. J Am Soc Nephrol 2007; 18: 699A
17. http://www.nhlbi.nih.gov/health/dci/Diseases/anemia/anemia- signsandsymptoms.html. Accessed on 14 February 2008
18. http://www.kidney.org/atoz/atozItem.cfm?id=125. Accessed on 14 February 2008
19. http://www.mayoclinic.com/health/iron-deficiency-anemia/DS00323/DSECTION= 2. Accessed on 14 February 2008
20. http://www.anemia.org/patients/faq. Accessed on 14 February 2008
21. http://rsnhope.rtrk.com/coupon/?scid=590676&cid=150779&tc= 08021409071339292&kw=4881115&dynamic-proxy=1&primary-serv=rsnhopepx. rtrk.com&se-refer=http%253A%252F%252Fwww.google. com%252Fsearch%253Fhl%253Den%2526q%253Drenal%252Bsupport%252Bnetwork. Accessed on 14 February 2008
22. Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-333
23. Lohr KN, Aaronson NK, Alonso J et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther 1996; 18: 979-992
24. Lohr KN. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11: 193-205
25. Paunonen SV, Ashton MS. The structured assessment of personality across cultures. J Cross Cult Psychol 1998, 29: 150-170
26. Besarab A, Bolton W, Browne J et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590
27. Beusterien K, Nissenson A, Port F et al. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996; 7: 763-773
28. Muirhead N, Keown P, Lei L et al. The relationship between achieved haemoglobin (Hb) & exercise tolerance. Poster presented at the Spring Clinical Meeting of the National Kidney Foundation, April 2-6, Dallas, TX, 2008. Poster 116. http://www.kidney.org/news/meetings/clinical/CM08 Abstracts.cfm. Accessed on 26 August 2008
29. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 1987; 40: 171-178